{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:19:21Z","timestamp":1768634361508,"version":"3.49.0"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":1464,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1093\/bja\/aet402","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T00:38:33Z","timestamp":1386895113000},"page":"i3-i17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"S1","title":["Perioperative management of antiplatelet therapy"],"prefix":"10.1016","volume":"111","author":[{"given":"A.D.","family":"Oprea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.M.","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aet402_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.thromres.2003.08.003","article-title":"Role of antiplatelet drugs in the prevention of cardiovascular events","volume":"110","author":"Tendera","year":"2003","journal-title":"Thromb Res"},{"key":"10.1093\/bja\/aet402_bib2","series-title":"Top 10 causes of death","year":"2013"},{"key":"10.1093\/bja\/aet402_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1213\/ANE.0b013e318203f38d","article-title":"Antiplatelet drugs: a review of their pharmacology and management in the perioperative period","volume":"112","author":"Hall","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet402_bib4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/01.RES.0000264509.36234.51","article-title":"Clinical aspects of platelet inhibitors and thrombus formation","volume":"100","author":"Meadows","year":"2007","journal-title":"Circ Res"},{"key":"10.1093\/bja\/aet402_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH03-07-0440","article-title":"Autologous platelets as a source of proteins for healing and tissue regeneration","volume":"91","author":"Anitua","year":"2004","journal-title":"Thromb Haemost"},{"issue":"Suppl. L)","key":"10.1093\/bja\/aet402_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurheartj\/16.suppl_L.8","article-title":"Coagulation and platelet activation pathways. A review of the key components and the way in which these can be manipulated","volume":"16","author":"B\u00fcller","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1093\/bja\/aet402_bib7","doi-asserted-by":"crossref","first-page":"15782","DOI":"10.1073\/pnas.1218880110","article-title":"Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide","volume":"110","author":"Kirkby","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/bja\/aet402_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/asheducation-2011.1.51","article-title":"The role of platelets in atherothrombosis","volume":"2011","author":"Kaplan","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1093\/bja\/aet402_bib9","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1093\/bja\/aet402_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.2008.07233.x","article-title":"Antiplatelet drugs","volume":"142","author":"De Meyer","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1093\/bja\/aet402_bib11","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.ijcard.2012.08.014","article-title":"Novel oral anticoagulants in acute coronary syndrome","volume":"167","author":"Costopoulos","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1093\/bja\/aet402_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI108132","article-title":"The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein","volume":"56","author":"Roth","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1093\/bja\/aet402_bib13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","article-title":"Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects","volume":"69","author":"Patrignani","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1093\/bja\/aet402_bib14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib15","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.STR.0000231683.43347.ec","article-title":"Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers","volume":"37","author":"Cox","year":"2006","journal-title":"Stroke"},{"key":"10.1093\/bja\/aet402_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00558267","article-title":"Pharmacokinetics of low-dose oral modified release, soluble and intravenous aspirin in man, and effects on platelet function","volume":"35","author":"Bochner","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1093\/bja\/aet402_bib17","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1093\/bja\/aet402_bib18","doi-asserted-by":"crossref","first-page":"976.e7","DOI":"10.1016\/j.ahj.2006.02.017","article-title":"Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers","volume":"151","author":"Karha","year":"2006","journal-title":"Am Heart J"},{"key":"10.1093\/bja\/aet402_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1378\/chest.114.5_Supplement.470S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects","volume":"114","author":"Patrono","year":"1998","journal-title":"Chest"},{"key":"10.1093\/bja\/aet402_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet402_bib21","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet402_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjmed.2011.01.018","article-title":"Effect of aspirin on mortality in the primary prevention of cardiovascular disease","volume":"124","author":"Raju","year":"2011","journal-title":"Am J Med"},{"key":"10.1093\/bja\/aet402_bib23","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet402_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","article-title":"Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement","volume":"150","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1093\/bja\/aet402_bib25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIR.0b013e31820faaf8","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20142011 update: a guideline from the American Heart Association","volume":"123","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib27","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jacc.2013.01.014","volume":"61","author":"Anderson","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/bja\/aet402_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2012.11.018","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/bja\/aet402_bib29","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.2013.7086","article-title":"Medical management after coronary stent implantation: a review","volume":"310","author":"Brilakis","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aet402_bib31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/eurheartj\/ehn417","article-title":"Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study","volume":"30","author":"Jolly","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1093\/bja\/aet402_bib32","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Mangano","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib34","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.CIR.77.6.1324","article-title":"Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study","volume":"77","author":"Goldman","year":"1988","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.57.3.326","article-title":"Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses","volume":"57","author":"Hart","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1093\/bja\/aet402_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aet402_bib37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIR.0b013e31820d8d78","volume":"124","author":"Brott","year":"2011","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"10.1093\/bja\/aet402_bib39","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jama.280.22.1930","article-title":"Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials","volume":"280","author":"He","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aet402_bib40","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/bja\/aer274","article-title":"Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial","volume":"107","author":"Mantz","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet402_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1540-8191.2007.00402.x","article-title":"Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis","volume":"22","author":"Alghamdi","year":"2007","journal-title":"J Card Surg"},{"key":"10.1093\/bja\/aet402_bib42","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.297.18.2018","article-title":"Aspirin dose for the prevention of cardiovascular disease: a systematic review","volume":"297","author":"Campbell","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aet402_bib43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00044011-199816040-00006","article-title":"Clopidogrel activities in patients with renal function impairment","volume":"16","author":"Deray","year":"1998","journal-title":"Clin Drug Investig"},{"key":"10.1093\/bja\/aet402_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/00912700022008973","article-title":"Cirrhosis does not affect the pharmacokinetics and pharmacodynamics of clopidogrel","volume":"40","author":"Slugg","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1093\/bja\/aet402_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.clinthera.2011.04.007","article-title":"Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrel","volume":"33","author":"Martin","year":"2011","journal-title":"Clin Ther"},{"key":"10.1093\/bja\/aet402_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2710.2009.01068.x","article-title":"Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease","volume":"34","author":"Small","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1093\/bja\/aet402_bib47","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1053\/j.jvca.2012.11.014","article-title":"ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly","volume":"27","author":"Oprea","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1093\/bja\/aet402_bib48","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMp0806848","article-title":"Prasugrel in clinical practice","volume":"361","author":"Bhatt","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib49","first-page":"MS24","article-title":"Ticagrelor\u2014a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?","volume":"15","author":"Kowalczyk","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1093\/bja\/aet402_bib50","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1345\/aph.1M548","article-title":"Efficacy and safety of ticagrelor: a reversible P2Y12 receptor antagonist","volume":"44","author":"Anderson","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1093\/bja\/aet402_bib51","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1177\/0091270011415526","article-title":"Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment","volume":"52","author":"Butler","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"Suppl. 1","key":"10.1093\/bja\/aet402_bib52","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/jth.12219","article-title":"Antiplatelet therapy: new pharmacological agents and changing paradigms","volume":"11","author":"Capodanno","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1093\/bja\/aet402_bib53","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1517\/13543780903136708","article-title":"Cangrelor: a novel P2Y12 receptor antagonist","volume":"18","author":"Norgard","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1093\/bja\/aet402_bib54","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1093\/bja\/aet402_bib55","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1093\/bja\/aet402_bib56","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1093\/bja\/aet402_bib57","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib58","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31822e80c3","volume":"124","author":"Rooke","year":"2011","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib59","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIR.0b013e3181fa3cf4","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"123","author":"Wann","year":"2011","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib61","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib62","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aet402_bib63","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aet402_bib64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet402_bib65","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib66","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib67","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1161\/CIRCULATIONAHA.108.833665","volume":"119","author":"Morrow","year":"2009","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib68","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/eurheartj\/ehn362","article-title":"Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial","volume":"29","author":"Murphy","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1093\/bja\/aet402_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet402_bib70","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib71","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"Bhatt","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib72","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ahj.2011.11.001","article-title":"Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction","volume":"163","author":"White","year":"2012","journal-title":"Am Heart J"},{"key":"10.1093\/bja\/aet402_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrd985","article-title":"Scientific and therapeutic advances in antiplatelet therapy","volume":"2","author":"Bhatt","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1093\/bja\/aet402_bib74","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/qjmed\/hcr069","article-title":"Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials","volume":"104","author":"Navarese","year":"2011","journal-title":"QJM"},{"key":"10.1093\/bja\/aet402_bib75","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1592\/phco.28.3.376","article-title":"Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting","volume":"28","author":"Pickard","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1093\/bja\/aet402_bib76","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/CIRCULATIONAHA.110.002683","volume":"123","author":"Hochholzer","year":"2011","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib77","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jtcvs.2012.07.059","article-title":"Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis","volume":"145","author":"Goodnough","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/bja\/aet402_bib78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.amjcard.2012.08.043","article-title":"Prasugrel monitoring and bleeding in real world patients","volume":"111","author":"Cayla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1093\/bja\/aet402_bib79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000350961","article-title":"Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive","volume":"126","author":"Serebruany","year":"2013","journal-title":"Cardiology"},{"key":"10.1093\/bja\/aet402_bib80","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib81","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0149-2918(01)80098-9","article-title":"Platelet glycoprotein IIb\/IIIa-receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: a review","volume":"23","author":"Truong","year":"2001","journal-title":"Clin Ther"},{"key":"10.1093\/bja\/aet402_bib82","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-0037-1616241","article-title":"Anti-GPIIb\/IIIa drugs: current strategies and future directions","volume":"86","author":"Coller","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1093\/bja\/aet402_bib83","first-page":"173","article-title":"High-dose abciximab during coronary angioplasty in a patient with essential thrombocytosis","volume":"10","author":"Kohl","year":"1998","journal-title":"J Invasive Cardiol"},{"key":"10.1093\/bja\/aet402_bib84","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.97.17.1680","article-title":"Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb\/IIIa receptor blockade","volume":"97","author":"Mascelli","year":"1998","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib85","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0002-9149(99)00321-5","article-title":"Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention","volume":"84","author":"Kereiakes","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1093\/bja\/aet402_bib86","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0090-9556(24)14939-2","article-title":"In vitro and in vivo studies on the metabolism of tirofiban","volume":"27","author":"Vickers","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1093\/bja\/aet402_bib87","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2125.2010.03879.x","article-title":"Anti-platelet therapy: glycoprotein IIb\u2013IIIa antagonists","volume":"72","author":"Schneider","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1093\/bja\/aet402_bib88","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/MJT.0b013e31804c7238","article-title":"Antiplatelet intervention in acute coronary syndrome","volume":"16","author":"Arora","year":"2009","journal-title":"Am J Ther"},{"key":"10.1093\/bja\/aet402_bib89","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0002-9343(00)00474-5","article-title":"The use of glycoprotein IIb\/IIIa inhibitors in patients with coronary artery disease","volume":"109","author":"Sabatine","year":"2000","journal-title":"Am J Med"},{"key":"10.1093\/bja\/aet402_bib90","first-page":"436","article-title":"The PURSUIT Trial Investigators. Platelet glycoprotein IIb\/IIIa in unstable angina: receptor suppression using integrilin therapy","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0002-9343(00)00453-8","article-title":"Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb\/IIIa receptor inhibitors: a pooled analysis of major clinical trials","volume":"109","author":"Memon","year":"2000","journal-title":"Am J Med"},{"key":"10.1093\/bja\/aet402_bib92","first-page":"481","article-title":"Acute stent thrombosis after early withdrawal of platelet glycoprotein IIb\/IIIa antagonists: potential rebound prothrombotic effect?","volume":"58","author":"Angiolillo","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1093\/bja\/aet402_bib93","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00392-011-0310-7","article-title":"Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation","volume":"100","author":"Diehl","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1093\/bja\/aet402_bib94","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bja\/aer298","article-title":"Determination of residual antiplatelet activity of clopidogrel before neuraxial injections","volume":"107","author":"Benzon","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet402_bib95","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehl334","article-title":"A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease","volume":"27","author":"Biondi-Zoccai","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1093\/bja\/aet402_bib96","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/01.anes.0000265168.52501.c7","article-title":"Late thrombosis of a drug-eluting stent presenting in the perioperative period","volume":"106","author":"de Souza","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aet402_bib97","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.amjcard.2006.12.025","article-title":"Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries","volume":"99","author":"Artang","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1093\/bja\/aet402_bib98","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet402_bib99","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2174\/1389450111314080008","article-title":"Perioperative handling of antiplatelet drugs. A critical appraisal","volume":"14","author":"Di Minno","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1093\/bja\/aet402_bib100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00007632-200003010-00010","article-title":"Predictors of blood transfusions in spinal instrumentation and fusion surgery","volume":"25","author":"Nuttall","year":"2000","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1093\/bja\/aet402_bib101","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0020-1383(03)00073-1","article-title":"The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures","volume":"35","author":"Manning","year":"2004","journal-title":"Injury"},{"key":"10.1093\/bja\/aet402_bib102","first-page":"1484","article-title":"Perioperative antiplatelet therapy","volume":"82","author":"Chassot","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1093\/bja\/aet402_bib103","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00000539-200109000-00009","article-title":"The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis","volume":"93","author":"Neilipovitz","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet402_bib104","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/bja\/aeq003","article-title":"To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial","volume":"104","author":"Oscarsson","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet402_bib105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00423-011-0867-7","article-title":"A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery\u2014the APAP trial (ISRCTN45810007)","volume":"397","author":"Antolovic","year":"2012","journal-title":"Langenbecks Arch Surg"},{"key":"10.1093\/bja\/aet402_bib106","first-page":"453","article-title":"The effect of preoperative aspirin use on postoperative bleeding and perioperative myocardial infarction in patients undergoing coronary artery bypass surgery","volume":"14","author":"Ghaffarinejad","year":"2007","journal-title":"Cardiol J"},{"key":"10.1093\/bja\/aet402_bib107","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1464-410X.1993.tb16027.x","article-title":"Aspirin and post-prostatectomy haemorrhage","volume":"71","author":"Thurston","year":"1993","journal-title":"Br J Urol"},{"key":"10.1093\/bja\/aet402_bib108","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00701-006-0868-4","article-title":"Low-dose aspirin before intracranial surgery\u2014results of a survey among neurosurgeons in Germany","volume":"148","author":"Korinth","year":"2006","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1093\/bja\/aet402_bib109","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2796.2005.01477.x","article-title":"Low-dose aspirin for secondary cardiovascular prevention\u2014cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation\u2014review and meta-analysis","volume":"257","author":"Burger","year":"2005","journal-title":"J Intern Med"},{"key":"10.1093\/bja\/aet402_bib110","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1160\/TH10-04-0217","volume":"105","author":"Korte","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1093\/bja\/aet402_bib111","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/ACO.0b013e3283340b1a","article-title":"Perioperative management of the patient with a coronary stent","volume":"23","author":"Popescu","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1093\/bja\/aet402_bib112","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aet402_bib113","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2005.02.086","article-title":"Late angiographic stent thrombosis (LAST) events with drug-eluting stents","volume":"45","author":"Ong","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/bja\/aet402_bib114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/bja\/aeh147","article-title":"Triggers of perioperative myocardial ischaemia and infarction","volume":"93","author":"Priebe","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet402_bib115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/bja\/aei063","article-title":"Perioperative myocardial infarction\u2014aetiology and prevention","volume":"95","author":"Priebe","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet402_bib116","first-page":"141","article-title":"Major noncardiac surgery following coronary stenting: when is it safe to operate?","volume":"63","author":"Sharma","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1093\/bja\/aet402_bib117","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11739-009-0265-0","article-title":"Perioperative handling of patients on antiplatelet therapy with need for surgery","volume":"4","author":"Di Minno","year":"2009","journal-title":"Intern Emerg Med"},{"key":"10.1093\/bja\/aet402_bib118","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1160\/TH10-08-0554","article-title":"Clopidogrel withdrawal: is there a \u2018rebound\u2019 phenomenon?","volume":"105","author":"Sambu","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1093\/bja\/aet402_bib119","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2007.09.001","volume":"50","author":"Fleisher","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/bja\/aet402_bib120","doi-asserted-by":"crossref","first-page":"w13263","DOI":"10.4414\/smw.2011.13263","article-title":"Drug-eluting coronary stents in clinical practice: lessons from the \u2018BAsel Stent Kosten-Effektivit\u00e4ts Trials\u2019 (BASKET). A review of the BASKET trials","volume":"141","author":"Pfisterer","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1093\/bja\/aet402_bib121","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation","volume":"297","author":"Eisenstein","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aet402_bib122","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"Park","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet402_bib123","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib124","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib125","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/bja\/aet402_bib126","doi-asserted-by":"crossref","first-page":"518968","DOI":"10.1155\/2013\/518968","article-title":"Dual antiplatelet therapy can be discontinued at three months after implantation of zotarolimus-eluting stent in patients with coronary artery disease","volume":"2013","author":"Wada","year":"2013","journal-title":"ISRN Cardiol"},{"key":"10.1093\/bja\/aet402_bib127","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jhm.227","article-title":"Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study","volume":"2","author":"Brotman","year":"2007","journal-title":"J Hosp Med"},{"key":"10.1093\/bja\/aet402_bib128","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.112.102715","article-title":"Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study","volume":"126","author":"Wijeysundera","year":"2012","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib129","first-page":"153","article-title":"Perioperative management of antiplatelet therapy in patients with drug-eluting stents","volume":"4","author":"Dimitrova","year":"2012","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"key":"10.1093\/bja\/aet402_bib130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.14219\/jada.archive.2007.0237","volume":"138","author":"Grines","year":"2007","journal-title":"J Am Dent Assoc"},{"key":"10.1093\/bja\/aet402_bib131","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.gie.2009.09.040","article-title":"Management of antithrombotic agents for endoscopic procedures","volume":"70","author":"Anderson","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1093\/bja\/aet402_bib132","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.amjcard.2011.05.029","article-title":"Safety of dental extractions during uninterrupted single or dual antiplatelet treatment","volume":"108","author":"Lillis","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1093\/bja\/aet402_bib133","first-page":"33","article-title":"Endoscopic procedures in patients under clopidogrel\/dual antiplatelet therapy: to do or not to do?","volume":"22","author":"Abdel Samie","year":"2013","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1093\/bja\/aet402_bib134","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5946\/ce.2013.46.4.395","article-title":"Biliary-pancreatic endoscopic and surgical procedures in patients under dual antiplatelet therapy: a single-center study","volume":"46","author":"Abdel Samie","year":"2013","journal-title":"Clin Endosc"},{"key":"10.1093\/bja\/aet402_bib135","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ophtha.2010.07.005","article-title":"Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group","volume":"118","author":"Mason","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1093\/bja\/aet402_bib136","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaad.2011.02.013","article-title":"Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation","volume":"65","author":"Cook-Norris","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1093\/bja\/aet402_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2013.05.092","article-title":"Discontinuation of preoperative clopidogrel is unnecessary in peripheral arterial surgery","author":"Saadeh","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1093\/bja\/aet402_bib138","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1258\/vasc.2011.oa0336","article-title":"Blood loss and complications following carotid endarterectomy in patients treated with clopidogrel","volume":"20","author":"Chechik","year":"2012","journal-title":"Vascular"},{"key":"10.1093\/bja\/aet402_bib139","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jvs.2011.03.003","article-title":"Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery","volume":"54","author":"Stone","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1093\/bja\/aet402_bib140","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jtcvs.2010.07.051","article-title":"General thoracic surgery is safe in patients taking clopidogrel (Plavix)","volume":"140","author":"Cerfolio","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/bja\/aet402_bib141","first-page":"77","article-title":"Lung resection for non-small cell lung cancer after prophylactic coronary angioplasty and stenting: short- and long-term results","volume":"67","author":"Voltolini","year":"2012","journal-title":"Minerva Chir"},{"key":"10.1093\/bja\/aet402_bib142","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11748-011-0775-3","article-title":"Management of patients with coronary stents in elective thoracic surgery","volume":"59","author":"Sonobe","year":"2011","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1093\/bja\/aet402_bib143","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.athoracsur.2011.07.052","article-title":"Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection","volume":"92","author":"Ceppa","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/bja\/aet402_bib144","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1055\/s-0032-1331037","article-title":"Management and outcomes of patients on preoperative Plavix (clopidogrel) undergoing general thoracic surgery","volume":"61","author":"Paul","year":"2012","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1093\/bja\/aet402_bib145","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.injury.2011.01.011","article-title":"The effect of clopidogrel and aspirin on blood loss in hip fracture surgery","volume":"42","author":"Chechik","year":"2011","journal-title":"Injury"},{"key":"10.1093\/bja\/aet402_bib146","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s11999-012-2306-7","article-title":"Perioperative clopidogrel and postoperative events after hip and knee arthroplasties","volume":"470","author":"Nandi","year":"2012","journal-title":"Clin Orthop Relat Res"},{"key":"10.1093\/bja\/aet402_bib147","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/BOT.0b013e318240d70f","article-title":"The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery","volume":"26","author":"Collinge","year":"2012","journal-title":"J Orthop Trauma"},{"key":"10.1093\/bja\/aet402_bib148","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mayocp.2012.11.007","article-title":"Safety of clopidogrel in hip fracture surgery","volume":"88","author":"Feely","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1093\/bja\/aet402_bib149","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.urology.2013.05.019","article-title":"The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy","volume":"82","author":"Toepfer","year":"2013","journal-title":"Urology"},{"key":"10.1093\/bja\/aet402_bib150","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.juro.2010.02.2391","article-title":"Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents","volume":"183","author":"Eberli","year":"2010","journal-title":"J Urol"},{"key":"10.1093\/bja\/aet402_bib151","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00345-010-0561-3","article-title":"Impact of oral anticoagulation on morbidity of transurethral resection of the prostate","volume":"29","author":"Descazeaud","year":"2011","journal-title":"World J Urol"},{"key":"10.1093\/bja\/aet402_bib152","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1308\/003588409X391820","article-title":"A survey of the peri-operative management of urological patients on clopidogrel","volume":"91","author":"Mukerji","year":"2009","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1093\/bja\/aet402_bib153","first-page":"291","article-title":"Dual antiplatelet treatment in patients candidates for abdominal surgery","volume":"83","author":"Illuminati","year":"2014","journal-title":"Ann Ital Chir"},{"key":"10.1093\/bja\/aet402_bib154","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archsurg.144.1.69","article-title":"Antiplatelet agents in the perioperative period","volume":"144","author":"O\u2019Riordan","year":"2009","journal-title":"Arch Surg"},{"key":"10.1093\/bja\/aet402_bib155","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1161\/CIR.0b013e31823b5fee","article-title":"2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Hillis","year":"2011","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet402_bib156","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01586154-201305000-00027","article-title":"Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and\/or clopidogrel before emergency surgery?","volume":"74","author":"Taylor","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1093\/bja\/aet402_bib157","doi-asserted-by":"crossref","DOI":"10.1378\/chest.13-0459","article-title":"Perioperative management of antiplatelet therapy in patients with a coronary stent who need non-cardiac surgery: a systematic review of clinical practice guidelines","author":"Darvish-Kazem","year":"2013","journal-title":"Chest"},{"key":"10.1093\/bja\/aet402_bib158","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.hlc.2009.10.008","article-title":"Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery","volume":"19","year":"2010","journal-title":"Heart Lung Circ"},{"key":"10.1093\/bja\/aet402_bib159","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.athoracsur.2012.07.086","article-title":"2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations","volume":"94","author":"Ferraris","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/bja\/aet402_bib160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3909\/ricm0498","article-title":"Bridging therapy in the perioperative management of patients with drug-eluting stents","volume":"10","author":"Chou","year":"2009","journal-title":"Rev Cardiovasc Med"},{"key":"10.1093\/bja\/aet402_bib161","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2012.04.016","article-title":"Safety of \u2018bridging\u2019 with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery","volume":"110","author":"Rassi","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1093\/bja\/aet402_bib162","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1592\/phco.30.4.420","article-title":"Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature","volume":"30","author":"Pickett","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1093\/bja\/aet402_bib163","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1345\/aph.1P728","article-title":"Extended-infusion eptifibatide to prevent stent thrombosis in a patient undergoing orthopedic surgery","volume":"45","author":"Lizza","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1093\/bja\/aet402_bib164","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12471-011-0197-y","article-title":"Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation","volume":"19","author":"Marcos","year":"2011","journal-title":"Neth Heart J"},{"key":"10.1093\/bja\/aet402_bib165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/bja\/aep373","article-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of \u2018bridging\u2019 antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel","volume":"104","author":"Savonitto","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet402_bib166","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4244\/EIJV9I2A35","article-title":"Outcomes of a preoperative \u2018bridging\u2019 strategy with glycoprotein IIb\/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration","volume":"9","author":"Alshawabkeh","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1093\/bja\/aet402_bib167","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HPC.0b013e31826c53cd","article-title":"Recommendations for management of antiplatelet therapy in patients undergoing elective noncardiac surgery after coronary stent implantation","volume":"11","author":"Huang","year":"2012","journal-title":"Crit Pathw Cardiol"},{"key":"10.1093\/bja\/aet402_bib168","first-page":"575","article-title":"Bridging with glycoprotein IIb\/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents","volume":"79","author":"Ben Morrison","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1093\/bja\/aet402_bib169","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aet402_bib170","first-page":"223","article-title":"Safety of glycoprotein IIb\/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery","volume":"20","author":"Cheng","year":"2004","journal-title":"Can J Cardiol"},{"key":"10.1093\/bja\/aet402_bib171","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1074248406299068","article-title":"Preoperative platelet inhibition with eptifibatide during coronary artery bypass grafting with cardiopulmonary bypass","volume":"12","author":"Dyke","year":"2007","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1093\/bja\/aet402_bib172","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AAP.0b013e3181c15c70","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)","volume":"35","author":"Horlocker","year":"2010","journal-title":"Reg Anesth Pain Med"},{"key":"10.1093\/bja\/aet402_bib173","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","article-title":"Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology","volume":"27","author":"Gogarten","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1093\/bja\/aet402_bib174","first-page":"479","article-title":"Use of eptifibatide as a bridge antiplatelet agent for intrathecal drug delivery system placement","volume":"15","author":"Sisk","year":"2012","journal-title":"Pain Physician"},{"key":"10.1093\/bja\/aet402_bib175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1213\/ANE.0b013e31825ab374","article-title":"Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction","volume":"115","author":"Bauer","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet402_bib176","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.jvca.2007.01.010","article-title":"Epidural catheters and drug-eluting stents: a challenging relationship","volume":"21","author":"Popescu","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217309273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217309273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/111\/suppl_1\/i3\/620351\/aet402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:32:55Z","timestamp":1757788375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217309273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":176,"alternative-id":["S0007091217309273"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aet402","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative management of antiplatelet therapy","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/bja\/aet402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Author(s). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}